Harm Jan Bogaard

29.2k total citations · 5 hit papers
310 papers, 12.5k citations indexed

About

Harm Jan Bogaard is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Harm Jan Bogaard has authored 310 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Pulmonary and Respiratory Medicine, 155 papers in Cardiology and Cardiovascular Medicine and 43 papers in Surgery. Recurrent topics in Harm Jan Bogaard's work include Pulmonary Hypertension Research and Treatments (219 papers), Cardiovascular Function and Risk Factors (88 papers) and Cardiovascular Issues in Pregnancy (34 papers). Harm Jan Bogaard is often cited by papers focused on Pulmonary Hypertension Research and Treatments (219 papers), Cardiovascular Function and Risk Factors (88 papers) and Cardiovascular Issues in Pregnancy (34 papers). Harm Jan Bogaard collaborates with scholars based in Netherlands, United States and France. Harm Jan Bogaard's co-authors include Anton Vonk Noordegraaf, Norbert F. Voelkel, Frances S. de Man, Nico Westerhof, Donatas Kraskauskas, Jose Gomez‐Arroyo, Anco Boonstra, Shiro Mizuno, J. Tim Marcus and Mariëlle C. van de Veerdonk and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Harm Jan Bogaard

289 papers receiving 12.3k citations

Hit Papers

Definitions and Diagnosis of Pulmonary Hypertension 2009 2026 2014 2020 2013 2011 2009 2015 2019 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Definitions and Diagnosis of Pulmonary Hypertension
    2013 1.3k citations Harm Jan Bogaard et al. profile →
  2. Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy
    2011 601 citations J. Tim Marcus, Harm Jan Bogaard et al. profile →
  3. The Right Ventricle Under Pressure
    2009 522 citations Harm Jan Bogaard, Anton Vonk Noordegraaf et al. profile →
  4. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
    2015 437 citations Benoît Ranchoux, Fabrice Antigny et al. Circulation profile →
  5. Anatomy, Function, and Dysfunction of the Right Ventricle
    2019 429 citations Harm Jan Bogaard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harm Jan Bogaard Netherlands 54 9.5k 7.0k 1.8k 1.8k 1.4k 310 12.5k
Paul M. Hassoun United States 64 11.6k 1.2× 6.7k 1.0× 2.6k 1.4× 1.9k 1.0× 1.9k 1.4× 279 16.0k
Élie Fadel France 66 9.3k 1.0× 4.1k 0.6× 2.1k 1.1× 2.9k 1.6× 1.1k 0.8× 355 12.8k
Stephan Rosenkranz Germany 54 5.2k 0.6× 5.6k 0.8× 1.9k 1.0× 1.3k 0.7× 860 0.6× 267 10.0k
Raymond L. Benza United States 48 8.8k 0.9× 7.1k 1.0× 1.3k 0.7× 2.3k 1.3× 955 0.7× 316 12.2k
Zhi‐Cheng Jing China 39 8.6k 0.9× 5.8k 0.8× 1.3k 0.7× 1.1k 0.6× 1.0k 0.7× 221 10.6k
David Montani France 67 13.8k 1.5× 6.7k 1.0× 2.3k 1.3× 2.1k 1.1× 1.3k 1.0× 397 16.6k
Patricia A. Thistlethwaite United States 42 4.2k 0.4× 3.3k 0.5× 2.2k 1.2× 1.4k 0.8× 823 0.6× 101 8.5k
Stuart W. Jamieson United States 53 4.9k 0.5× 4.2k 0.6× 1.1k 0.6× 3.0k 1.7× 1.4k 1.0× 164 9.0k
Steeve Provencher Canada 53 6.2k 0.7× 3.4k 0.5× 2.0k 1.1× 874 0.5× 617 0.4× 187 8.3k
Toru Satoh Japan 42 6.5k 0.7× 5.1k 0.7× 1.1k 0.6× 1.1k 0.6× 901 0.7× 201 9.2k

Countries citing papers authored by Harm Jan Bogaard

Since Specialization
Citations

This map shows the geographic impact of Harm Jan Bogaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm Jan Bogaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm Jan Bogaard more than expected).

Fields of papers citing papers by Harm Jan Bogaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm Jan Bogaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm Jan Bogaard. The network helps show where Harm Jan Bogaard may publish in the future.

Co-authorship network of co-authors of Harm Jan Bogaard

This figure shows the co-authorship network connecting the top 25 collaborators of Harm Jan Bogaard. A scholar is included among the top collaborators of Harm Jan Bogaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harm Jan Bogaard. Harm Jan Bogaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peters, James E., et al.. (2024). Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. Nature Communications. 15(1). 744–744. 8 indexed citations
3.
Rajagopal, Sudarshan, Harm Jan Bogaard, Mohammed S.M. Elbaz, et al.. (2024). Emerging multimodality imaging techniques for the pulmonary circulation. European Respiratory Journal. 64(4). 2401128–2401128. 10 indexed citations
4.
Yoshida, Keimei, Jessie van Wezenbeek, Frances S. de Man, et al.. (2024). Tricuspid regurgitation in pulmonary arterial hypertension: a right ventricular volumetric and functional analysis. European Respiratory Journal. 63(6). 2301696–2301696. 4 indexed citations
5.
Bogaard, Harm Jan, et al.. (2023). P2.26-02 Patient-Reported Symptom Monitoring Improves 1-Year Quality of Life in Lung Cancer Patients; the SYMPRO-Lung Trial. Journal of Thoracic Oncology. 18(11). S400–S400.
6.
Wezenbeek, Jessie van, Stine Andersen, Anco Boonstra, et al.. (2023). Long-Term Effects of Pulmonary Endarterectomy on Right Ventricular Stiffness and Fibrosis in Chronic Thromboembolic Pulmonary Hypertension. Circulation Heart Failure. 16(10). e010336–e010336. 9 indexed citations
7.
Post, Edward P., Jip Ramaker, Tonny Lagerweij, et al.. (2023). Discrimination Between Pre‐ and Postcapillary Pulmonary Hypertension Using Platelet RNA. Journal of the American Heart Association. 12(13). e028447–e028447.
8.
Handoko, M. Louis, Lilian J. Meijboom, Esther J. Nossent, et al.. (2022). Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. ERJ Open Research. 8(2). 564–2021. 3 indexed citations
9.
Brabander, Justin de, Patrick Smeele, Hessel Peters‐Sengers, et al.. (2022). Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients. European Respiratory Journal. 60(6). 2200780–2200780. 19 indexed citations
10.
Boon, Gudula J.A.M., Wilbert B. van den Hout, Stefano Barco, et al.. (2021). A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension. ERJ Open Research. 7(3). 719–2020. 13 indexed citations
11.
Wezenbeek, Jessie van, Sophia‐Anastasia Mouratoglou, Lilian J. Meijboom, et al.. (2021). Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload. Circulation Heart Failure. 15(2). e008726–e008726. 17 indexed citations
12.
Houweling, Arjan C., et al.. (2021). Uptake and Patient Perspectives on Additional Testing for Novel Disease-Associated Genes: Lessons from a PAH Cohort. Genes. 12(10). 1540–1540. 1 indexed citations
13.
Liddle, John, Jaap D. van Buul, Robert H. Bates, et al.. (2020). Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity. Journal of Cell Science. 133(9). 26 indexed citations
14.
Manz, Xue D., Hugo J. Albers, Petr Symersky, et al.. (2020). In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time. Journal of Visualized Experiments. 2 indexed citations
15.
Post, Marco C., Jasper J. van der Smagt, Frances S. de Man, et al.. (2020). Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension Patients. Genes. 11(10). 1191–1191. 26 indexed citations
16.
Gomez‐Puerto, Maria Catalina, Robert Szulcek, Maarten van Dinther, et al.. (2019). Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. The Journal of Pathology. 249(3). 356–367. 37 indexed citations
17.
Labate, Valentina, et al.. (2017). Clinical Cases session- Diagnosis and management of cardiomyopathies: overcoming the challenges. European Heart Journal - Cardiovascular Imaging. 18(suppl_3). iii6–iii9.
18.
Ranchoux, Benoît, Fabrice Antigny, Catherine Rücker‐Martin, et al.. (2015). Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation. 131(11). 1006–1018. 437 indexed citations breakdown →
19.
Szulcek, Robert, Harm Jan Bogaard, & Geerten P. van Nieuw Amerongen. (2014). Electric Cell-substrate Impedance Sensing for the Quantification of Endothelial Proliferation, Barrier Function, and Motility. Journal of Visualized Experiments. 33 indexed citations
20.
Bogaard, Harm Jan, Ramesh Natarajan, Scott C. Henderson, et al.. (2009). Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure. Circulation. 120(20). 1951–1960. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul M. Hassoun Breakdown of academic impact, for papers by Élie Fadel Breakdown of academic impact, for papers by Stephan Rosenkranz Breakdown of academic impact, for papers by Raymond L. Benza Breakdown of academic impact, for papers by Zhi‐Cheng Jing Breakdown of academic impact, for papers by David Montani Breakdown of academic impact, for papers by Patricia A. Thistlethwaite Breakdown of academic impact, for papers by Stuart W. Jamieson Breakdown of academic impact, for papers by Steeve Provencher Breakdown of academic impact, for papers by Toru Satoh
Rankless by CCL
2026